共 1 页 当前第 1 页 返回检索页| 1 | 药品名称 | APRESOLINE |
| 申请号 | 008303 | 产品号 | 001 |
| 活性成分 | HYDRALAZINE HYDROCHLORIDE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
|
| 2 | 药品名称 | APRESOLINE |
| 申请号 | 008303 | 产品号 | 002 |
| 活性成分 | HYDRALAZINE HYDROCHLORIDE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
|
| 3 | 药品名称 | APRESOLINE |
| 申请号 | 008303 | 产品号 | 003 |
| 活性成分 | HYDRALAZINE HYDROCHLORIDE | 市场状态 | 停止上市 |
| 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
|
| 4 | 药品名称 | APRESOLINE |
| 申请号 | 008303 | 产品号 | 004 |
| 活性成分 | HYDRALAZINE HYDROCHLORIDE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
|
| 5 | 药品名称 | APRESOLINE |
| 申请号 | 008303 | 产品号 | 005 |
| 活性成分 | HYDRALAZINE HYDROCHLORIDE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
|
| 6 | 药品名称 | SERPASIL-APRESOLINE |
| 申请号 | 009296 | 产品号 | 002 |
| 活性成分 | HYDRALAZINE HYDROCHLORIDE; RESERPINE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 50MG;0.2MG |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
|
| 7 | 药品名称 | SERPASIL-APRESOLINE |
| 申请号 | 009296 | 产品号 | 004 |
| 活性成分 | HYDRALAZINE HYDROCHLORIDE; RESERPINE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 25MG;0.1MG |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
|
| 8 | 药品名称 | APRESOLINE-ESIDRIX |
| 申请号 | 012026 | 产品号 | 002 |
| 活性成分 | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 25MG;15MG |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | NOVARTIS PHARMACEUTICALS CORP
|